CYBN Stock Analysis: Buy, Sell, or Hold?
CYBN - Cybin Inc.
$8.28
0.10 (1.22%)
▲
5d:
+0.85%
30d:
+50.27%
90d:
+33.33%
BUY
HIGH Confidence
Last Updated: January 2, 2026
Earnings: Feb 09, 2026
6d
Get Alerted When CYBN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CYBN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: CYBN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: CYBN is currently trading at $8.28, which is considered slightly low relative to its 30-day fair value range of $8.22 to $8.61.
Technical Outlook: Technically, CYBN is showing sideways momentum. Immediate support is located at $6.75, while resistance sits at $9.12.
Market Sentiment: CYBN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $48.00 (+479.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CYBN is showing sideways momentum. Immediate support is located at $6.75, while resistance sits at $9.12.
Market Sentiment: CYBN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $48.00 (+479.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$8.22 -
$8.61
Company Quality Score
58/100
(HOLD)
Options IV Signal
45th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
89.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 45th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 479.7% below Wall St target ($48.00)
Fair Price Analysis
30-Day Fair Range
$8.22 -
$8.61
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$1.25
(15.1%)
Support & Resistance Levels
Support Level
$6.75
Resistance Level
$9.12
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-2.05
Wall Street Target
$48.00
(+479.7%)
Last updated: February 02, 2026 2:22 PM ET
Data refreshes hourly during market hours. Next update: 3:22 PM
Data refreshes hourly during market hours. Next update: 3:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CYBN showing a specific setup today?
Featured in Portfolios
CYBN is a key holding in these high-performance investment strategies.
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 63 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 48 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 62 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$847 | 54 HOLD |
